CYCLACEL PHARMACEUTICALS - CYCC 6 PERP (CYCCP)
US23254L2079
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.43M | -22.55M | -21.20M | -18.89M | -8.45M | |||
| Depreciation Amortization | 13.00K | 31.00K | 30.00K | 40.00K | 20.00K | |||
| Change In Working Capital | 2.10M | 5.01M | -1.21M | -1.03M | 150.00K | |||
| Interest Paid | N/A | 266.00K | 210.00K | 20.00K | 40.00K | |||
| Taxes Paid | 2.00K | 2.00K | 3.31M | 1.36M | 1.29M | |||
| Other non cash items | 770.00K | 1.40M | 1.55M | 1.33M | 340.00K | |||
| OPERATING CASH FLOW | -10.54M | -16.11M | -20.83M | -18.54M | -7.93M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -6.00K | -10.00K | -30.00K | -100.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | 0.00 | -6.00K | -10.00K | -30.00K | -100.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 7.26M | 1.05M | 3.20M | 21.94M | 29.71M | |||
| Dividend Paid | N/A | -201.00K | -200.00K | -200.00K | -200.00K | |||
| FINANCING CASH FLOW | 7.21M | 848.00K | 3.00M | 21.74M | 29.50M | |||
| Exchange Rate Effect | 374.00K | 303.00K | -380.00K | -20.00K | 50.00K | |||
| CHANGE IN CASH | -2.96M | -14.97M | -18.22M | 3.15M | 21.52M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.54M | -16.11M | -20.83M | -18.54M | -7.93M | |||
| Capital Expenditure | 0.00 | -6.00K | -10.00K | -30.00K | -100.00K | |||
| FREE CASH FLOW | -10.54M | -16.12M | -20.84M | -18.57M | -8.03M | |||
All data in USD